CRP and adult-onset Still disease: Inflammatory markers such as C-reactive protein, erythrocyte sedimentation rate, and ferritin were significantly decreased, and dosage of glucocorticoids can be rapidly and effectively reduced, all of which indicates the ideal effect of TCZ therapy for refractory AOSD patients.